These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10401786)

  • 1. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
    Muriel MP; Bernard V; Levey AI; Laribi O; Abrous DN; Agid Y; Bloch B; Hirsch EC
    Ann Neurol; 1999 Jul; 46(1):103-11. PubMed ID: 10401786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation.
    Tratnjek L; Glavan G; Višnjar T; Živin M
    Eur J Neurosci; 2016 Apr; 43(7):885-98. PubMed ID: 26750488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
    Di Rocco A; Werner P
    Ann Neurol; 2000 Jan; 47(1):136-7. PubMed ID: 10632116
    [No Abstract]   [Full Text] [Related]  

  • 4. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
    Muriel MP; Orieux G; Hirsch EC
    Mov Disord; 2002 Nov; 17(6):1174-9. PubMed ID: 12465054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
    Bernard V; Gardiol A; Faucheux B; Bloch B; Agid Y; Hirsch EC
    J Comp Neurol; 1996 May; 368(4):553-68. PubMed ID: 8744443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boolean analysis shows a high proportion of dopamine D
    Rivas-Santisteban R; Rico AJ; Muñoz A; Rodríguez-Pérez AI; Reyes-Resina I; Navarro G; Labandeira-García JL; Lanciego JL; Franco R
    Neurobiol Dis; 2023 Nov; 188():106341. PubMed ID: 37918757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.
    Franco R; Casadó-Anguera V; Muñoz A; Petrovic M; Navarro G; Moreno E; Lanciego JL; Labandeira-García JL; Cortés A; Casadó V
    Mol Neurobiol; 2016 Oct; 53(8):5436-45. PubMed ID: 26452359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.
    Corvol JC; Muriel MP; Valjent E; Féger J; Hanoun N; Girault JA; Hirsch EC; Hervé D
    J Neurosci; 2004 Aug; 24(31):7007-14. PubMed ID: 15295036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Perez XA; Zhang D; Bordia T; Quik M
    Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Zhang K; Chammas C; Soghomonian JJ
    Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Koski SK; Leino S; Panula P; Rannanpää S; Salminen O
    Neurosci Lett; 2020 Jun; 729():134932. PubMed ID: 32224226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors.
    Rioux L; Gagnon C; Gaudin DP; Di Paolo T; Bédard PJ
    Neuroscience; 1993 Sep; 56(1):45-51. PubMed ID: 8232916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.